Armistice Capital’s Confluent CFLT Stock Holding History

Armistice Capital’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-124,000	Closed	-$9.45M	–	149
2021 Q4	$9.45M	Buy	+124,000	New	+$8.94M	0.15%	94

Other funds holding CFLT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Armistice Capital's CFLT Position: Q1 2022 in Review

Armistice Capital sold out of Confluent (CFLT) in Q1 2022, closing a stake of 124,000 shares — an estimated $9.45M sold.

Armistice Capital first reported a position in CFLT in Q4 2021 and held it in 1 quarter. The position peaked at $9.45M in Q4 2021. 213 funds tracked by Wall St. Rank hold CFLT as of Q1 2022.

Armistice Capital reported no remaining Confluent position as of Q1 2022 after selling out during the quarter.
Armistice Capital sold 124,000 Confluent shares in Q1 2022, an estimated $9.45M.
Armistice Capital first reported a position in Confluent in Q4 2021 and held it in 1 quarter.
Armistice Capital's Confluent position peaked at $9.45M in Q4 2021.
213 funds tracked by Wall St. Rank held Confluent as of Q1 2022.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.